| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Transcriptional Up-Regulation of Fatty Acid Oxidation
Center for Integrative Genomics (S.G., B.D., L.M., W.W.), University of Lausanne, CH-1015 Lausanne, Switzerland; the Molecular Nutrition Unit and the Montreal Diabetes Research Center (C.N., R.R., M.-L.P., V.D.-A., M.P.), University of Montreal, Montreal, Quebec, Canada H2L 4M1; Hopital Rangueil (R.B.), 31403 Toulouse, France; and the Division of Medical Genetics (R.R.), Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland
Address all correspondence and requests for reprints to: Dr. Marc Prentki, Centre de Recherche, Centre Hospitalier de lUniversité de Montréal, Pavillon de Sève, Y4603, 1560 Sherbrooke East, Montreal, Quebec, Canada H2L 4M1. E-mail: marc.prentki{at}umontreal.ca.
The cellular response to fasting and starvation in tissues such as heart, skeletal muscle, and liver requires peroxisome proliferator-activated receptor-
(PPAR
)-dependent up-regulation of energy metabolism toward fatty acid oxidation (FAO). PPAR
null (PPAR
KO) mice develop hyperinsulinemic hypoglycemia in the fasting state, and we previously showed that PPAR
expression is increased in islets at low glucose. On this basis, we hypothesized that enhanced PPAR
expression and FAO, via depletion of lipid-signaling molecule(s) for insulin exocytosis, are also involved in the normal adaptive response of the islet to fasting. Fasted PPAR
KO mice compared with wild-type mice had supranormal ip glucose tolerance due to increased plasma insulin levels. Isolated islets from the PPAR
null mice had a 44% reduction in FAO, normal glucose use and oxidation, and enhanced glucose-induced insulin secretion. In normal rats, fasting for 24 h increased islet PPAR
, carnitine palmitoyltransferase 1, and uncoupling protein-2 mRNA expression by 60%, 62%, and 82%, respectively. The data are consistent with the view that PPAR
, via transcriptionally up-regulating islet FAO, can reduce insulin secretion, and that this mechanism is involved in the normal physiological response of the pancreatic islet to fasting such that hypoglycemia is avoided.
This article has been cited by other articles:
![]() |
M. Kebede, J. Favaloro, J. E. Gunton, D. R. Laybutt, M. Shaw, N. Wong, B. C. Fam, K. Aston-Mourney, C. Rantzau, A. Zulli, et al. Fructose-1,6-Bisphosphatase Overexpression in Pancreatic {beta}-Cells Results in Reduced Insulin Secretion: A New Mechanism for Fat-Induced Impairment of {beta}-Cell Function Diabetes, July 1, 2008; 57(7): 1887 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Kapoor, J. Locke, K. Colclough, J. Wales, J. J. Conn, A. T. Hattersley, S. Ellard, and K. Hussain Persistent Hyperinsulinemic Hypoglycemia and Maturity-Onset Diabetes of the Young Due to Heterozygous HNF4A Mutations Diabetes, June 1, 2008; 57(6): 1659 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Martens, A. Vervoort, M. Van de Casteele, G. Stange, K. Hellemans, H. V. Van Thi, F. Schuit, and D. Pipeleers Specificity in Beta Cell Expression of L-3-Hydroxyacyl-CoA Dehydrogenase, Short Chain, and Potential Role in Down-regulating Insulin Release J. Biol. Chem., July 20, 2007; 282(29): 21134 - 21144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Holness, G. K. Greenwood, N. D. Smith, and M. C. Sugden Peroxisome Proliferator-Activated Receptor-{alpha} and Glucocorticoids Interactively Regulate Insulin Secretion During Pregnancy Diabetes, December 1, 2006; 55(12): 3501 - 3508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Nolan, M. S.R. Madiraju, V. Delghingaro-Augusto, M.-L. Peyot, and M. Prentki Fatty Acid Signaling in the {beta}-Cell and Insulin Secretion Diabetes, December 1, 2006; 55(Supplement_2): S16 - S23. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Knauf, J. Rieusset, M. Foretz, P. D. Cani, M. Uldry, M. Hosokawa, E. Martinez, M. Bringart, A. Waget, S. Kersten, et al. Peroxisome Proliferator-Activated Receptor-{alpha}-Null Mice Have Increased White Adipose Tissue Glucose Utilization, GLUT4, and Fat Mass: Role in Liver and Brain Endocrinology, September 1, 2006; 147(9): 4067 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lalloyer, B. Vandewalle, F. Percevault, G. Torpier, J. Kerr-Conte, M. Oosterveer, R. Paumelle, J.-C. Fruchart, F. Kuipers, F. Pattou, et al. Peroxisome Proliferator-Activated Receptor {alpha} Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets Diabetes, June 1, 2006; 55(6): 1605 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Corton and H. M. Brown-Borg Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1 in Caloric Restriction and Other Models of Longevity J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1494 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Terauchi and T. Kadowaki Peroxisome Proliferator-Activated Receptors and Insulin Secretion Endocrinology, August 1, 2005; 146(8): 3263 - 3265. [Full Text] [PDF] |
||||
![]() |
K. Ravnskjaer, M. Boergesen, B. Rubi, J. K. Larsen, T. Nielsen, J. Fridriksson, P. Maechler, and S. Mandrup Peroxisome Proliferator-Activated Receptor {alpha} (PPAR{alpha}) Potentiates, whereas PPAR{gamma} Attenuates, Glucose-Stimulated Insulin Secretion in Pancreatic {beta}-Cells Endocrinology, August 1, 2005; 146(8): 3266 - 3276. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |